TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AKTS

Aktis Oncology, Inc.

Healthcare · Biotechnology

22.90$ +0.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Aktis Oncology, Inc. (AKTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 265 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AKTS
Line item 2013 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 4.5 4.5 18 29 48 71 161 138 122 326 265
0.0 4.4 4.3 10 16 32 46 92 132 100 301 230
0.0 4.3 4.2 9.6 15 30 44 80 129 30 37 38
0.0 4.3 4.2 9.6 15 30 44 80 129 98 297 227
0.2 0.3 0.4 3.8 4.8 5.3
0.0 0.0 0.2 0.1 0.1 0.1 4.1 7.5 2.2
8.1 15 6.5
0.0 0.1 0.2 0.3 0.4 0.5 9.0 15 13
0.0 0.3 1.9 3.1 15 22 30 58 158 169 414 411
0.0 0.1 0.5 1.4 2.6 3.2 6.1 13 5.3 6.2 19 31
0.0 0.0 0.5 0.3 0.9 1.5 1.3 1.3
0.0 0.1 0.5 0.1 0.2 2.1 3.6 0.5 1.0 1.9 1.7
0.0 4.2 2.7 15 14 26 41 103 -19 -46 -88 -146
0.0 -1.3 -6.7 -16 -38 -67 -104 -207 -20 -49 -93 -157
13 13 17 21 28 34 54 35 35 35 53

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?